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Morphometric grading of invasive ductal breast cancer.
1. Thresholds for nuclear grade
P Kronqvist, T Kuopio and Y Collan
Department of Pathology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
Summary We analysed 170 histological samples of invasive ductal breast cancer from years 1988-91 by computerized nuclear
morphometry, to find objective and quantitative thresholds for nuclear grade. Based on Kaplan-Meier curves reflecting survival and
recurrence of disease and univariate analysis by Cox's regression, optimal thresholds were determined for features related to nuclear size
and size variation. In our material, with mean follow-up time of 5 years 9 months, the determined thresholds for nuclear profile area (32 jim2
and 47 jim2), nuclear diameter (6.4 gm and 7.4 ,um) and mean shortest nuclear axis (4.8 ,um and 6.4gm) best separated the cases with
favourable, intermediate and unfavourable course of disease. In this material from the era of mammography and adjuvant therapy, the mean
shortest nuclear axis was found to be a significant prognostic factor, with a risk ratio (RR) exceeded only by that of tumour size (RRs 2.9- and
3.5-fold respectively). The results suggest that morphometric grading criteria can be developed for application in Bloom-Richardson grading
and in the Nottingham Prognostic Index.
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The value ofhistological grading in breast cancer is well acknowl-
edged (Stierer et al, 1991; Simpson and Page, 1994). A point of
critique, however, is the subjectivity of the method. The
Nottingham Prognostic Index (NPI) (Elston and Ellis, 1991)
includes a modification of Bloom-Richardson grading (Bloom
and Richardson, 1957), which has shown high prognostic poten-
tial. The semiquantitative criteria of the Nottingham method are
also associated with improved reproducibility of histological
grading (Frierson et al, 1995; Robbins et al, 1995).
Encouraged by the results ofthe Nottingham group, we have set
out to elaborate further the Bloom-Richardson grading by
applying quantitative criteria. Our aim is to develop a morpho-
metric grading system for invasive ductal breast cancer based on
numerical thresholds for nuclear grade, tubular formation and
mitotic activity. In the present preliminary study, we determine
nuclear size and shape measurement thresholds that best separate
the patients into different prognostic subgroups. The determina-
tions are based on breast cancer survival and recurrence in the
studied patient material.
MATERIAL AND METHODS
Patient material
Histological samples of a total of 170 cases of invasive ductal
breast cancer diagnosed and treated at Turku University Hospital,
Finland, during the years 1988-91 were available for morpho-
metric measurements. The pertinent clinical data of the patients
are summarized in Table 1. Complete follow-up histories and penr-
operative specimens from the primary tumours were available.
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Patients with previous breast cancer in the same or the other breast
were excluded, as well as patients with distant metastases detected
within 1 month from the date of diagnosis. Metastases were
detected by routine chest and bone radiographs, laboratory tests
reflecting bone and liver metabolism and by cytological and histo-
logical samples when possible. None of the patients received
preoperative radiation therapy or other adjuvant treatment. All
patients were treated with radical or modified radical mastectomy
with axillary evacuation. Post-operative early adjuvant systemic
therapy was given to 28% of patients; 20% received endocrine
therapy and 8% chemotherapy. The follow-up examination was
Table 1 Characteristics of the patients (n = 170)
Mean age at diagnosis (range)
Menopausal status
No of premenopausal women
(< 52 years)
No of postmenopausal women
(> 52 years)
Axillary lymph node status
No of positive patients
No of negative patients
Mean tumour size (range)a
Mean follow up time (range)
No of cases with recurrence
Causes of death during follow up
Breast cancer
Other cancer
Other
59.1 years (31.6-97.6 years)
58 (34%)
112 (66%)
70 (41%)
100 (59%)
2.9 cm (0.5-15.0 cm)
5 years 9 months (2months -
8 years 11months)
56 (33%)
37 (22%)
6 (4%)
10 (6%)
aTumour size was defined as the maximum tumour diameter as measured
peroperatively by the operating surgeon or, in cases of non-palpable disease,
during the histological examination by the pathologist.
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carried out every 3 months during the first post-operative year,
every 6 months during the second and third post-operative years
and thereafter yearly, until 5 years of follow-up was completed.
The causes of death were based on autopsy reports, death certifi-
cates and patient histories.
The overall survival rate was 69%, as calculated from the whole
material as the proportion ofpatients alive at 5 years offollow-up.
The breast cancer-related survival rate was 76%, and was deter-
mined at 5 years offollow-up from the material excluding patients
who had died ofcauses other than breast cancer.
Morphometric method
The histological samples used for morphometric measurements
were fixed in buffered formalin (pH 7.0), embedded in paraffin,
sectioned at 5 gm and stained with haematoxylin and eosin.
Special consideration was placed on the nuclear morphometric
methodology to ensure reproducibility of results. Different
sampling rules and optimal sample sizes in nuclear morphometry
have been tested in association with a previous paper (Kronqvist et
al, 1995). The sources for inter- and intraobserver variation were
recently surveyed (Kronqvist et al, 1997) and the reproducibility
of the applied morphometric method was found to be excellent in
terms ofboth selection of measurement area and measuring proce-
dure itself. As a result of this experience in nuclear morphometry,
we first in each case chose a representative slide, placing special
emphasis on the quality of the histological details. Next, we iden-
tified the area of the actively proliferating cells at the invasive
border of the most cellular part of the tumour, rejecting areas
showing necrosis and inflammation. A digitizing interactive video
overlay system (Promis, Almere, The Netherlands) was used for
nuclear measurements. By using a digitizer board (PIP-512B
video digitizer board; Matrox Electronic Systems, Dorval,
Quebec, Canada) and a final monitor magnification of approxi-
mately 2500 x, the nuclear profiles were traced on the monitor
screen (MultiSync 3D Color Monitor; NEC, Japan). To ensure
validity of the results, the morphometric instrument was carefully
calibrated before each measurement session. In each sample, an
average of 10-15 microscope fields were screened and 50 consec-
utive tumour cell nuclei were measured by outlining their profiles
with a computer mouse. The preconditions for measuring a
nucleus were an undoubtful cancer origin and clearly identified
nuclear borders. The measurement of one sample took approxi-
mately 20-30 min. After completing the measurement of one
sample, 11 morphometric variables with their basic statistics were
automatically calculated by the computer.
Statistical analysis
All morphometric variables were reviewed throughout their range
with the help of Kaplan-Meier analysis on the basis of the whole
follow-up time (Cutler and Ederer, 1958). Each candidate for a
cut-off point was tested by drawing curves for survival time and
disease-free period (Statistica for Windows release 5.0; StatSoft,
Tulsa, OK, USA). Log-rank tests were used to test the statistical
significances of the difference between the curves. The cut-off
points showing the best curve separation, and correspondingly the
highest statistical significance, presented us with the nuclear
morphometric thresholds most suitable for grade limits.
Altogether, about 2000 Kaplan-Meier curves were screened to
find the optimal thresholds. Univariate analyses based on Cox's
regression were also applied to the determined thresholds. The
prognostic significance of the morphometric nuclear grading was
estimated and compared with that of tumour size and axillary
lymph node status by risk ratios (RRs) of breast cancer death in
univariate and multivariate analyses (SAS System for Windows
release 6.12; SAS Institute, Cary, NC, USA).
The determined thresholds were further tested with the help of
grading efficiency (GE) (Galen and Gambino, 1975; Collan et al,
1992) and receiver-operating characteristic (ROC) analysis
(Zweig and Campbell, 1993; Kairisto and Poola, 1995). The GE
represents the efficiency of distinguishing alive patients from
those dead of breast cancer at 5 years of follow-up. The efficien-
cies and the ROC curves were produced with the help of the
GraphROC software (GraphROC for Windows, University of
Turku, Department ofClinical Chemistry, Turku, Finland).
RESULTS
The thresholds for nuclear size-related features determined by
Kaplan-Meier analysis are presented in Table 2. The thresholds
derived from Kaplan-Meier analysis and from P-value curves of
univariate analysis by Cox's regression (Figure 1) were practically
identical. The thresholds were also the same in survival- and recur-
rence-based analyses, but the statistical significance associated
with survival was better. For mean nuclear profile area, mean
nuclear diameter and mean shortest nuclear axis, two thresholds -
a lower and a higher limit -could be found. Only one cut-offpoint
could be determined for mean nuclear perimeter and mean longest
nuclear axis and for standard deviation of nuclear profile area.
Features describing nuclear shape showed no association with
prognosis and thresholds for these could not be determined.
With the help of the determined thresholds for mean nuclear
profile area, mean nuclear diameter and mean shortest nuclear
Table 2 Means (standard deviations, s.d.) of morphometric nuclear measurements and morphometrically determined thresholds
(P-values) for the nuclear variables in breast cancer based on Kaplan-Meier curves and log rank tests in 170 samples. Some
morphometric features could be associated with one and some with two thresholds
Two thresholds
Variable Mean (s.d.) One threshold Lower Higher
Mean area (pm2) 38.6 (15.0) 32 (0.013) 47 (0.006)
Mean diameter (pm) 6.8 (1.2) 6.4 (0.029) 7.4 (0.005)
Mean shortest axis (pm) 5.8 (1.1) 4.8 (0.017) 6.4 (0.003)
s.d. of area (pm2) 14.1 (5.7) 10.5 (0.038)
Mean perimeter (pm) 22.6 (4.2) 24 (0.003)
Mean longest axis (pm) 8.6 (1.6) 8.0 (0.010)
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Figure 1 The distribution of P-values from univariate analysis of Cox's
regression associated with the different cut-off point candidates for mean
shortest nuclear axis. The type of analysis differs from log-rank tests of
Kaplan-Meier curves, but the cut-off points showing the highest statistical
significances are practically identical in both analyses
Table 3 A summary of the Kaplan-Meier analysis and proportion of patients
dead of breast cancer in material divided into prognostic groups according to
the morphometric thresholds
Variable n Patients dead during P-valuea
follow-up (%)
Mean area (pm2) 0.003
<32 64 8 (12.5)
32-47 62 12 (19.4)
>47 44 17 (38.6)
Mean diameter (tim) 0.004
<6.4 73 10 (13.7)
6.4-7.4 50 9(18)
>7.4 47 18 (38.3)
Mean shortest axis (pm) <0.001
<4.8 35 3 (8.6)
4.8-6.4 91 16 (17.6)
>6.4 44 18 (40.9)
s.d. of area (pm2) 0.038
<10.5 46 5 (10 9)
>10.5 124 32 (25.8)
Mean perimeter (pm) 0.003
<24 111 17 (16.0)
>24 59 20 (33.9)
Mean longest axis (pm) 0.01
<8.0 65 8 (12.3)
>8.0 105 29 (27.6)
alog rank test
axis, the patients in our sample could be divided into three
subgroups with favourable, intermediate and unfavourable prog-
nosis (Table 3, Figure 2). In contrast, mean nuclear perimeter,
mean longest nuclear axis and standard deviation ofnuclear profile
area revealed only two prognostic subgroups.
Risk ratios of univariate analysis ofCox's regression among the
morphometric variables are summarized in Table 4. The RRs for
each morphometric feature are produced by comparing the
survival ofpatients associated with measurement results above the
determined cut-off points with the survival of patients showing
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Figure 2 The survival curves based on mean shortest nuclear axis in the
whole material of 170 cases of invasive ductal breast cancer (P < 0.001) (A),
and among axillary lymph node-negative (difference not statistically
significant) (B) and axillary lymph node-positive (P < 0.001) (C) patients. In
the whole material and among axillary lymph node-positive patients the
determined cut-off points (a, < 4.8 pm; b, 4.8-6.4 pm; c, > 6.4pm) divide the
cases into three prognostic groups with a different survival from disease
measurement values below the cut-off point. The highest RRs
were associated with the thresholds for mean shortest nuclear axis
and mean nuclear profile area and the higher threshold for mean
nuclear diameter.
The RRs determined by univariate and multivariate analyses
associated with mean shortest nuclear axis at higher threshold,
tumour size and axillary lymph node status are summarized in
Table 5. Based on analyses of all patients, mean shortest nuclear
axis was associated with the second highest RRs after tumour size.
Concerning axillary lymph node-positive patients, mean shortest
nuclear axis and tumour size showed equal risk ratios. In contrast,
analyses of axillary lymph node-negative patients did not result in
statistically significant risk ratios.
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Table 4 Results of univariate analysis presented by risk ratios (RRs) with 95% confidence intervals (95% Cls) in the material divided into prognostic groups
according to the determined morphometric thresholds
Variable One thresholda Two thresholdsa
Lower Higher
P-value RR 95% Cl P-value RR 95%CI P-value RR 95% Cl
Mean area (jm2) 0.010 2.7 1.2-5.8 0.002 2.7 1.4-5.2
Mean diameter (,um) 0.015 2.5 1.2-5.1 0.002 2.8 1.5-5.3
Mean shortest axis (jim) 0.038 3.5 1.1-11.3 <0.001 2.9 1.5-5.6
s.d. of area (jim2) 0.045 2.6 1.0-6.7
Mean perimeter (,m) 0.005 2.6 1.3-4.9
Mean longest axis (,um) 0.014 2.6 1.2-5.9
aThe thresholds used in the analysis are presented in Table 2.
Table 5 Summary of univariate and multivariate analyses of mean shortest nuclear axis, tumour size and axillary lymph node status based on survival of
disease concerning all patients and axillary lymph node-positive patients (node +). The risk ratios of axillary lymph node-negative patients were not statistically
significant in our material
Variable Group Univariate analysis Multivariate analysis
P-value RR 95% CI P-value RR 95% Cl
Mean shortest axis, <6.4/>6.4,m All <0.001 2.9 1.5-5.6 0.007 2.5 1.3-4.7
Node + <0.001 3.6 1.5-8.4 0.011 3.0 1.3-7.0
Tumour size, <3/>3 cm All <0.001 3.5 1.8-6.7 0.003 2.8 1.4-5.6
Node + 0.014 3.1 1.2-7.5 0.017 3.0 1.2-7.3
Axillary lymph node status, -/+ All 0.01 2.5 1.2-4.5 0.176 1.6 0.8-3.2
Table 6 Grading efficiencies for the thresholds determir
Meier analysis. Also maximum efficiencies with maximun
thresholds and areas under curve (AUC) are shown. All c
based on breast cancer survival at 5 years of follow-up
Variable, thresholda
Mean area (gm2)
32
47
Mean diameter (pm)
6.4
7.4
Mean shortest axis (,um)
4.8
6.4
s.d. of area (jm2)
10.5
Mean perimeter (>m)
24
Mean longest axis (jm)
8.0
Efficiency Max efficiency
0.587
0.594
0.615
0.608
0.562
0.620
0.555
0.608
0.576
0.590
0.615
0.620
0.561
0.629
0.590
aThresholds based on log rank test of Kaplan-Meier ana
bThresholds associated with maximum grading efficiency
Table 6 summarizes the breast cancer survil
efficiencies of the determined thresholds at 5 y
The maximum efficiency cut-points ofROC ana
in line with the thresholds by Kaplan-Meic
analyses and support the application of the dete
in grading. The area under the ROC curve (AU(
and indicates a moderate grading potential for
features.
ned by Kaplan -
n efficiency DISCUSSION
efficiencies are As a part of our aim to produce a quantitative morphometric
grading system, this study introduces thresholds for mophometric
Thresholdb AUC nuclear grading. Among the morphometric features analysed, the
thresholds for mean shortest nuclear axis most efficiently divide
49.4 0.607 the patients into different prognostic subgroups. The thresholds for
the morphometric features analysed were the same after
6.4 0.614 KKaplan-Meier analyses and univariate analyses by Cox's regres-
sion, and they could be confirmed also by analysis of maximum
efficiencies. The thresholds were identical when the analysis was
6.4 0.621 based on breast cancer survival and disease-free period and they
can therefore be applied to predicting both breast cancer death and
10.6 0.528 recurrence. In this paper, we present only results on tissue fixed in
4% buffered formaldehyde, but corresponding thresholds can also
23.0 0.614 be determined for frozen material. As freezing causes shrinkage of
tumour cell nuclei (Baak et al, 1982; Kronqvist et al, 1995), the
thresholds for frozen sections are 12-38% lower than those based
on formalin-fixed material. According to our experiences, frozen
material also give data perfectly in line with the present results
lysis. when the degree of nuclear shrinkage is mathematically corrected.
The prognostic value of nuclear size and size variation in breast
cancer is widely acknowledged on the basis of subjective and
quantitative assessments of nuclear pleomorphism (Baak et al,
val-based grading 1982; Schondorf and Naujoks, 1985; Stierer et al, 1991).
ears of follow-up. Guidelines for breast cancer prognostication based on nuclear
lysis are very well morphometric features in histological samples have been
-r and univariate presented before (van der Linden et al, 1986; Uyterlinde, 1991).
rmined thresholds Baak et al (1985) successfully applied the thresholds 37 jim2 and
C) is 0.621 at best 53 jim2 in distinction between different prognostic groups of
the morphometric breast cancer patients. Our thresholds are based on systematic
analysis of the follow-up information of breast cancer patients.
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Thresholds derived on the basis of this type of analysis have not
been available earlier.
Subjective grading has been successfully used for breast cancer
prognostication (Davis et al, 1986; Henson et al, 1991; Dalton et
al, 1994) but, by applying quantitative methodology, standardiza-
tion and accuracy of grading can still be promoted. Because of
early detection and modern treatment modalities, the prognosis of
breast cancer has changed in the past few years. The use of both
mammographic screening (Tabar et al, 1992; Larsson et al, 1996;
Moss et al, 1994) and adjuvant therapy (Early Breast Cancer
Trialists' Collaborative group, 1992; Robert, 1994; Styblo and
Wood, 1996) have improved the outcome of breast cancer. As the
nature of the disease has changed from the days of Bloom and
Richardson, it is also necessary that new modifications ofhistolog-
ical grading are developed. The material in our study is quite
recent and therefore, the presented morphometric principles and
criteria should be readily applicable to the present patient material
and treatment modalities.
In breast cancer, the morphometric view of nuclear size and size
variation varies considerably. Our measurements represent the
lower end of the scale of results presented in the literature. The
published results suggest that in histological sections of breast
cancer tissue the range of morphometrically determined nuclear
area is between 24.4 ,um2 and 67.8 tm2 and standard deviation of
nuclear area between 12.8 ,um2 and 18.35 ,um2 (Baak et al, 1982;
Aaltomaa, 1991; Pienta and Coffey, 1991; Ladekarl and Sorensen,
1993; Kronqvist et al, 1995). However, values as high as 131.0
tm2 and 31.0 tm2 have also been reported for mean nuclear profile
area and standard deviation of nuclear profile area respectively
(Aaltomaa et al, 1993). We feel that most differences in the
observed nuclear size and size variation among different publica-
tions are due to factors related to patient material and application
of the morphometric method. In our experience, a strictly stan-
dardized and uniform measuring technique, with regular calibra-
tion of the computerized morphometric equipment with a
micrometer slide, ensures reproducible results applicable to prog-
nostication and classification on the basis of nuclear size
(Kronqvist et al, 1997). The obvious advantages of nuclear
morphometry also include inexpensive equipment, conceptually
simple methods and reproducible results, which also facilitate the
use ofmorphometry in routine pathology practice. Compared with
subjective grading the morphometric method is, however, some-
what more time-consuming and demands specially trained
personnel.
To sum up, the scope of the present study was to produce quan-
titative criteria for nuclear grading in breast cancer, and by this
means to improve the consistency and the accuracy ofthe method.
We have been able to introduce, for nuclear morphometric features
in invasive ductal breast cancer, quantitative thresholds which can
be developed for application in the traditional Bloom and
Richardson grading as well as in other classification systems such
as the Nottingham Prognostic Index. Our results suggest that the
nuclear morphometric grading system can be used as the basis for
treatment decisions in breast cancer and that mean shortest nuclear
axis is the most significant morphometric prognosticator among
the features tested. Obviously, this paper on morphometric nuclear
grading is a preliminary one and other features of histological
grading have to be similarly analysed for quantitative thresholds
before we can speak of a true morphometric grading system. We
are already in progress with corresponding studies on mitotic
activity and tubular formation.
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